Volume 85, Issue 3, Pages (March 2014)

Slides:



Advertisements
Similar presentations
Indoxyl Sulfate and p-Cresyl Sulfate in Chronic Kidney Disease
Advertisements

Volume 85, Issue 3, Pages (March 2014)
Volume 79, Issue 9, Pages (May 2011)
Summary of Recommendation Statements
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
Indoxyl Sulfate and p-Cresyl Sulfate in Chronic Kidney Disease
Progressive thermopreconditioning attenuates rat cardiac ischemia/reperfusion injury by mitochondria-mediated antioxidant and antiapoptotic mechanisms 
Shining light on vitamin D trials in chronic kidney disease
Why NAD+ Declines during Aging: It’s Destroyed
Figure 2 The potential effects of nicotinamide adenine
Volume 91, Issue 3, Pages (March 2017)
Shunsuke Furuta, David R.W. Jayne  Kidney International 
Sirtuin and metabolic kidney disease
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease  Stacey Ruiz, Pablo E. Pergola, Richard.
Propofol as a panacea for acute kidney injury?
Sirtuins Caught in the Act
Volume 79, Issue 1, Pages (January 2011)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 77, Issue 1, Pages 5-6 (January 2010)
Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid  M. Stiborová, E. Frei, H.H. Schmeiser  Kidney.
Yasemin Sirin, Hermann Pavenstädt  Kidney International 
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Sanjeev Noel, Abdel R.A. Hamad, Hamid Rabb  Kidney International 
Lipid redistribution in renal dysfunction
Volume 82, Issue 8, Pages (October 2012)
Volume 76, Issue 11, Pages (December 2009)
Volume 76, Issue 3, Pages (August 2009)
Volume 80, Issue 5, Pages (September 2011)
Proteasome inhibitor-based therapy for antibody-mediated rejection
Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury  Yasuhiko Yamamoto, Hiroshi.
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Juliana Saraiva Anjos, MD, Ludmila F. M. F
Volume 77, Issue 7, Pages (April 2010)
Yuji Yamaguchi, Vincent J. Hearing, Akira Maeda, Akimichi Morita 
Disaster nephrology: crush injury and beyond
Volume 27, Issue 1, Pages 5-7 (January 2018)
The AhR–Nrf2 Pathway in Keratinocytes: On the Road to Chemoprevention?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 8, Pages (October 2008)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Calcium sensing in podocytes
Wayel Jassem, Nigel D. Heaton  Kidney International 
Volume 78, Issue 5, Pages (September 2010)
Nephrology Crossword: Glomerulonephritis
Volume 13, Issue 4, Pages (April 2011)
Hydrogen: another gas with therapeutic potential
Volume 73, Issue 9, Pages (May 2008)
Cardiovascular risk assessment in kidney transplantation
Volume 82, Issue 9, Pages (November 2012)
Immunity unmasks APOL1 in collapsing glomerulopathy
Volume 80, Issue 10, Pages (November 2011)
Volume 79, Issue 12, Pages (June 2011)
Volume 77, Issue 10, Pages (May 2010)
Volume 76, Issue 1, Pages 8-10 (July 2009)
Pediatric acute kidney injury: The use of the RIFLE criteria
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Volume 81, Issue 8, Pages (April 2012)
Volume 84, Issue 6, Pages (December 2013)
The international realities of live donor kidney transplantation
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
The Management of Diabetic Neuropathy in CKD
Volume 80, Issue 9, Pages (November 2011)
Volume 75, Issue 8, Pages (April 2009)
The cyctoprotective endoplasmic reticulum (ER) stress mechanism [32].
The Ebf1 knockout mouse and glomerular maturation
Ronen Levi, Justin Silver  Kidney International 
DisSIRTing on LXR and Cholesterol Metabolism
Presentation transcript:

Volume 85, Issue 3, Pages 496-498 (March 2014) β-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation  Christopher Y. Lu  Kidney International  Volume 85, Issue 3, Pages 496-498 (March 2014) DOI: 10.1038/ki.2013.419 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 β-Lapachone, NQO1, NAD+, and SIRT1 at the crossroads of metabolism, injury, and inflammation during cisplatin nephrotoxicity. Blue arrows and blue boxes show processes elucidated by Oh et al.1 Red arrows show additional processes that may be involved in cisplatin nephrotoxicity. AKI, acute kidney injury; ARE, antioxidant response element; ER, endoplasmic reticulum; Keap, Kelch-like ECH-associated protein 1; NADH, nicotinamide adenine dinucleotide; NF-κB, nuclear factor-κB; NQO1, NAD+(P)H:quinone oxidoreductase 1; Nrf2, nuclear factor-erythroid 2-related factor 2; PARP1, poly-(ADP-ribose) polymerase-1; ROS, reactive oxygen species; SIRT1, sirtuin 1 (silent information regulator 2 (Sir2) protein 1). Kidney International 2014 85, 496-498DOI: (10.1038/ki.2013.419) Copyright © 2014 International Society of Nephrology Terms and Conditions